Assay Designs snares Stressgen Bioreagents

Assay Designs of Ann Arbor, Michigan, has acquired Canada's Stressgen Bioreagents. Stressgen develops and markets antibodies, proteins and related kits to life sciences researchers worldwide. No financial details were released. Dr. Russell Hart, Assay Designs' co-founder and president, said, "The combination of Assay Designs and Stressgen creates exciting opportunities. For example, it allows us to leverage Stressgen's expertise in heat shock proteins, active kinases and antibodies to develop new, unique kits. We also plan to take advantage of Stressgen's West coast location to extend customer service and technical support coverage for Assay Designs' customers, and vice versa."

- read this press release for more

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Early-stage biotech Elevian has raised $15 million as it looks to target multiple age-related diseases.

A month after seeing a "robust immune response" from a clutch of RSV vaccine hopefuls, GlaxoSmithKline is kicking off a key late-stage test.

The half-dose was given to some participants due to an error but is now AstraZeneca’s best hope of delivering efficacy comparable to mRNA vaccines.